Stocks/LCID

LCID three-lens brief

Evidence-based stock research on LCID. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$4.47$5.91$33.70

Performance

1W
-2.9%
1M
+17.5%
3M
-31.2%
6M
-47.9%
YTD
-44.1%
1Y
-74.7%
3Y
5Y
LCID · Nightly brief
Inspect

Analyst mean target $8.40 — 42% above current (10 analysts). · Trading at 5% of its 52-week range — deep in the lower band.

  • Trading at 5% of its 52-week range — deep in the lower band.
  • Currently unprofitable on a trailing basis — no P/E multiple available.
  • Analyst mean target $8.40 — 42% above current (10 analysts).
  • Negative free cash flow last quarterly (-$3.04B).
  • 8-K filing filed 2026-07-02.

LCID closed at $5.91 (+1.29%) as of 2026-07-10. Market cap: $2.30B. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $8.40 — 42% above current (10 analysts).. Concerns: trading at 5% of its 52-week range — deep in the lower band.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $282.46M, net income -$1.13B, free cash flow -$3.04B. Watching for: 2026-08-04 earnings release (24 days out).

Market ✓· Fundamentals ✓· 2 events
Informational only · Not investment advice
Three-lens method

Why three lenses on LCID, not one.

A single reasoning model has blind spots it doesn’t know about. We examine LCIDacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/LCID"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath LCID brief"></iframe>